A Clinical and Angiographic Scoring System to Predict the Probability of Successful First-Attempt Percutaneous Coronary Intervention in Patients With Total Chronic Coronary Occlusion  by Alessandrino, Giuseppe et al.
J A C C : C A R D I O V A S C U L A R I N T E R V E N T I O N S V O L . 8 , N O . 1 2 , 2 0 1 5
ª 2 0 1 5 B Y T H E A M E R I C A N C O L L E G E O F C A R D I O L O G Y F O U N D A T I O N I S S N 1 9 3 6 - 8 7 9 8 / $ 3 6 . 0 0
P U B L I S H E D B Y E L S E V I E R I N C . h t t p : / / d x . d o i . o r g / 1 0 . 1 0 1 6 / j . j c i n . 2 0 1 5 . 0 7 . 0 0 9CLINICAL RESEARCH
CORONARYA Clinical and Angiographic Scoring
System to Predict the Probability of
Successful First-Attempt Percutaneous
Coronary Intervention in Patients With
Total Chronic Coronary Occlusion
Giuseppe Alessandrino, MD, Bernard Chevalier, MD, Thierry Lefèvre, MD, Francesca Sanguineti, MD,
Philippe Garot, MD, Thierry Unterseeh, MD, Thomas Hovasse, MD, Marie-Claude Morice, MD, Yves Louvard, MDABSTRACTFro
co
to
MaOBJECTIVES This study sought to develop a scoring model predicting percutaneous coronary intervention (PCI)
success in chronic total occlusions.
BACKGROUND Coronary chronic total occlusion is the lesion subtype in which angioplasty is most likely to fail. Chronic
total occlusion for PCI (CTO-PCI) failure is associated with higher 1-year mortality and major adverse cardiac events
compared with successful CTO-PCI. Although several independent predictors of ﬁnal procedural success have been
identiﬁed, no study has yet produced a model predicting ﬁnal procedural outcome.
METHODS Data from 1,657 consecutive patients who underwent a ﬁrst-attempt CTO-PCI were prospectively collected.
The scoring model was developed in a derivation cohort of 1,143 patients (70%) using a multivariable stepwise analysis to
identify independent predictors of CTO-PCI failure. The model was then validated in the remaining 514 (30%).
RESULTS The overall procedural success rate was 72.5%. Independent predictors of CTO-PCI failure were identiﬁed
and included in the clinical and lesion-related score (CL-score) as follows: previous coronary artery bypass graft
surgery þ1.5 (odds ratio [OR]: 2.49, 95% conﬁdence interval [CI]: 1.56 to 3.96), previous myocardial infarction þ1 (OR:
1.6, 95% CI: 1.17 to 2.2), severe lesion calciﬁcation þ2 (OR: 2.72, 95% CI :1.78 to 4.16), longer CTOs þ1.5 ($20 mm
OR: 2.04, 95% CI: 1.54 to 2.7), non–left anterior descending coronary artery location þ1 (OR: 1.56, 95% CI: 1.14 to
2.15), and blunt stump morphology þ1 (OR: 1.39, 95% CI: 1.05 to 1.81). Score values of 0 to 1, >1 and <3, $3 and <5,
and $5 identiﬁed subgroups at high, intermediate, low, and very low probability, respectively, of CTO-PCI success
(derivation cohort: 84.9%, 74.9%, 58%, and 31.9%; p < 0,0001; validation cohort: 88.3%, 73.1%, 59.4%, and
46.2%; p < 0.0001).
CONCLUSIONS This clinical and angiographic score predicted the ﬁnal CTO-PCI procedural outcome of our study
population. (J Am Coll Cardiol Intv 2015;8:1540–8) © 2015 by the American College of Cardiology Foundation.m the Institut Cardiovasculaire Paris Sud, Hôpital Privé Jacques Cartier, Générale de Santé, Massy, France. Dr. Chevalier is a
nsultant for Abbott Vascular, Medtronic, and Terumo. All other authors have reported that they have no relationships relevant
the contents of this paper to disclose.
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AB BR E V I A T I O N S
AND ACRONYM S
CABG = coronary artery bypass
graft surgery
CI = conﬁdence interval
CL-score = clinical and lesion-
related score
CTO = chronic total occlusion
CTO-PCI = chronic total
occlusion for percutaneous
coronary intervention
J-CTO = Japanese chronic total
occlusion score
LAD = left anterior descending
coronary artery
MI = myocardial infarction
OR = odds ratio
PCI = percutaneous coronary
intervention
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1541S everal studies have shown that successfulpercutaneous coronary intervention (PCI) forcoronary chronic total occlusion (CTO) is asso-
ciated with a better outcome in terms of reduced mor-
tality and 1-year major adverse cardiac events
compared with CTO-PCI failure (1–5).
Although new dedicated devices and guidewires
have had a favorable impact on procedural success
(6,7), CTO remains the type of lesion in which an-
gioplasty is most likely to fail. In a multicenter study,
Morino et al. (8), developed an angiographic scoring
system to stratify CTO-PCI complexity. Recently,
Nombela-Franco et al. (9) conﬁrmed that the Japa-
nese chronic total occlusion (J-CTO) score is a useful
tool for predicting successful guidewire crossing of
the CTO within 30 min, but they failed to demonstrate
the value of such a model in predicting ﬁnal proce-
dural success. Although the predictive value of
angiographic parameters has been thoroughly inves-
tigated, it has been recently reported that even clin-
ical characteristics may have a predictive role (10,11).SEE PAGE 1549To obtain a scoring model able to predict ﬁnal
CTO-PCI success, we prospectively analyzed a cohort
of patients who underwent CTO-PCI, taking into ac-
count both clinical and angiographic parameters.
METHODS
We analyzed 1,671 consecutive patients with CTO
treated by PCI from January 2004 to December 2013.
All patients provided written informed consent. The
study protocol was approved by the local ethics
committee, and all procedures were performed ac-
cording to current international guidelines (12,13).
We reviewed the database of the 1,671 patients who
underwent CTO-PCI procedures at ICPS (Massy and
Quincy hospitals, France).
DEFINITIONS AND PATIENT SELECTION. A CTO was
deﬁned by angiography as a coronary occlusion
without antegrade ﬁlling of the distal vessel other
than via collaterals. The duration of the occlusion had
to be more than 3 months, as estimated from the
onset of clinical events including myocardial infar-
ction (MI), sudden onset or worsening of chest
symptoms, or evidenced by angiography. When the
duration of the occlusion was uncertain, and the in-
vestigators had no clear evidence that it was <3
months, the patient was included in the analysis.
Quantitative assessment was performed using the
Quant-Cor QCA software package (CAAS II, V.5.0,
Pie Medical Imaging, Maastricht, the Netherlands).Previous MI was deﬁned as an MI (non–ST-
segment elevationMI or ST-segment elevation
myocardial infarction) with a culprit lesion
other than the CTO or an MI that had occurred
at least 3 months before the CTO-PCI.
Previous coronary artery bypass graft sur-
gery (CABG) was deﬁned as a previous CABG
of the CTO vessel carried out at least 3
months before the CTO-PCI procedure.
Blunt morphology of the lesion: the lesion
was classiﬁed as a blunt morphology type if
the occluded segment did not end in the
shape of a funnel.
Calciﬁed lesions: presence of calciﬁcation
was classiﬁed according to 3 categories—mild,
moderate, and severe.
The measurement of the degree of retro-
grade collateral supply was performed using a
collateral grading system, according to the
Rentrop classiﬁcation (14).
Bending lesion: this was deﬁned as any lesion with
at least 1 bend of >45 assessed by angiography along
the whole length of the occluded segment.
Length of occlusion: occlusion length was cate-
gorized as either <20 or $20 mm according to the
EuroCTO Club consensus (15).
Successful procedure was deﬁned as the achieve-
ment of <30% residual diameter stenosis as assessed
by quantitative coronary angiography and associated
with Thrombolysis In Myocardial Infarction ﬂow
grade 3.
To improve the accuracy of lesion analysis, all
cases were reviewed by our core laboratory before
and after the procedure.
PATIENT SELECTION. Patients in whom CTO-PCI was
attempted in the setting of acute cardiogenic shock
were excluded. In addition, to minimize confounders,
only the ﬁrst CTO-PCI attempts performed during the
enrolling period were included in the analysis. If 2 or
more CTO PCIs were attempted during the same
procedure, the patient was excluded. If a single CTO
lesion or 2 different CTO lesions were attempted in 2
or more separate procedures during the enrolling
period, only the ﬁrst procedure was considered as a
ﬁrst attempt and subsequently included in the
analysis.
DEFINITION OF COMPLICATIONS. MI was deﬁned as
>3 times the upper limit of normal creatine phos-
phokinase release, in the absence of escalating crea-
tine phosphokinase before PCI.
Ostial dissection and major pericardial effusion
were deﬁned, respectively, as angiographic evidence
TABLE 1 Baseline Characteristics of the Overall Population of
“First Intention” PCI (N ¼ 1,657)
Age, yrs 64  11.1
Female 257 (15.5)
BMI, kg/m2 27.3  4.1
Hypertension 995 (60)
Dyslipidemia 1,042 (63)
Diabetes 484 (29.2)
Smoking 451 (27.2)
Previous MI 352 (21.2)
Previous PCI 625 (37.7)
Previous stroke 21 (1.3)
Previous CABG 124 (7.5)
LVEF <40% 253 (15.2)
Stable angina 934 (56.3)
IV class CKD 7 (0.4)
Multivessel CAD 926 (55.9)
Lesion-related characteristics
CTO site
LAD 506 (30.5)
RCA 764 (46.1)
LCX 381 (23)
LM 6 (0.4)
Ostial CTO 59 (3.6)
Blunt stump 889 (53.6)
Tortuous 251 (15.1)
Calciﬁed lesion 943 (56.8)
Mild 483 (29.1)
Moderate 299 (18)
Severe 161 (9.7)
Lesion length $20 mm 580 (35)
Lesion length, mm 20.2  21.1
Rentrop class 3 732 (44.1)
In-stent CTO 166 (10)
J-CTO score 1.62  0.89
Procedural characteristics
Radial access 1,092 (65.9)
Retrograde approach 154 (9.3)
Contralateral injection 600 (36.2)
Procedural time, min 87.3  49.1
Total medium contrast amount, ml 259  155
Monorail balloon support 95 (5.7)
Coaxial balloon support 369 (22.5)
Microcatheter support 849 (51.2)
Parallel wire 279 (16.8)
Anchor balloon 151 (9.1)
Anchor wire 100 (6)
Rotational atherectomy 25 (1.5)
Tornus 35 (2.1)
Values are mean  SD, or n (%).
BMI ¼ body mass index; CABG ¼ coronary artery bypass graft surgery; CAD ¼
coronary artery disease; CKD ¼ chronic kidney disease; CTO ¼ chronic total
occlusion; J-CTO ¼ Japanese chronic total occlusion score; LAD ¼ left anterior
descending coronary artery; LCX ¼ left circumﬂex coronary artery; LM ¼ left main;
LVEF ¼ left ventricular ejection fraction; MI ¼ myocardial infarction; PCI ¼
percutaneous coronary intervention; RCA ¼ right coronary artery.
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1542of signiﬁcant staining of medium contrast in sub-
intimal strata of the coronary wall involving the
coronary ostium and pericardial effusion requiring
pericardiocentesis.
STATISTICAL ANALYSIS. Continuous variables were
presented as mean  SD or median (25th to 75th
percentiles) according to distribution. Categorical
variables were expressed as absolute numbers and
percentages. Chi-square test was applied to evaluate
the association between qualitative variables. The
Student t test was used to compare quantitative var-
iables between the 2 groups. A predictive score was
developed on the basis of a derivation set of
1,143 randomly selected patients (70%). The score was
then validated in the remaining 514 patients
(30%; validation cohort). In the derivation cohort, a
backward stepwise multivariable logistic regression
was used to select a set of independent predictive
variables. Independent variables were then scored
according to the corresponding odds ratio (OR). The
score validation was performed by logistic regression
analysis of the validation cohort. Comparison of the
success rates among score classes was also performed
with a chi-square test for trend. A receiver-operating
characteristic curve analysis was performed to
compare the predictive impact of the new score with
that of the J-CTO score.
To assess whether technical changes and im-
provement during the study period had an impact on
our predictive variables, procedures were classiﬁed in
chronological order and divided into 2 subgroups
according to the procedural period: group A (January
2004 to December 2010) and group B (January 2011 to
December 2013).
RESULTS
Between January 2004 and December 2013, 14 oper-
ators performed 1,833 CTO-PCI procedures in 1,671
patients of whom 14 were excluded because CTO-PCI
was attempted in the setting of cardiogenic shock. A
total of 1,657 patients with 1,657 ﬁrst CTO-PCI at-
tempts were enrolled. Procedural success was ach-
ieved in 1,202 of 1,657 procedures, accounting for an
overall success rate of 72.5%.
BASELINE POPULATION. The baseline characteris-
tics of the 1,657 study patients are reported in Table 1.
The median age of the population was 64 years;
27% of patients had diabetes, and 21.2%, 37.7%, and
7.5% had prior MI, prior PCI, and prior CABG,
respectively. The most common indication for PCI
was stable angina (56.3%), and the majority of pa-
tients had multivessel disease (55.9%).
TABLE 3 Univariable Analysis: Clinical and Lesion-Related
Characteristics According to Procedural Outcome of the
Derivation Subgroup
Failure
(n ¼ 316)
Success
(n ¼ 827) p Value
Age, yrs 65.1  11.9 63.5  11.4 0.1
Female 15.2 15.6 0.86
BMI, kg/m2 28  4.4 27.3  3.9 0.024
Hypertension 61.1 60.1 0.051
Dyslipidemia 69.3 61.8 0.018
Diabetes 30.4 27.7 0.36
Smoking 28.6 24.6 0.16
Previous MI 27.8 18 <0.0001
Previous PCI 44.3 33.4 0.001
Previous stroke 1.3 1.2 0.93
Previous CABG 12.3 5.6 <0.0001
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1543The right coronary artery was the most common
site of CTO (46.1%), followed by the left anterior
descending coronary artery (LAD) (30.5%), circumﬂex
(23.0%), and left main (0.4%); 56.8% of lesions were
calciﬁed, 15.1% were tortuous, and 35.0% were long
($20 mm). Class 3 Rentrop collateralization was re-
ported in 44.1% of cases.
The majority of procedures were transradial
(65.9%) and were carried out via an anterograde ap-
proach (90.6%). Contralateral injection was per-
formed in 36.2% of patients. Attempts at achieving
guidewire support were made using a microcatheter
in the majority of cases (51.2%), followed by a coaxial
balloon (22.5%) and by a monorail balloon (5.7%). The
mean J-CTO score was 1.62  0.89.TABLE 2 Clinical and Lesion-Related Characteristics in the
Derivation and Validation Groups
Derivation Set
(n ¼ 1,143)
Validation Set
(n ¼ 514) p Value
Age, yrs 63.7  11.5 64.7  11 0.93
Female 15.6 15.5 0.96
BMI, kg/m2 27.5  4 27.1  4.4 0.81
Hypertension 60.9 58.4 0.34
Dyslipidemia 63.9 60.9 0.24
Diabetes 28.4 30.9 0.31
Smoking 25.7 30.9 0.027
Previous MI 20.7 22.4 0.47
Previous PCI 36.4 40.7 0.11
Previous stroke 1.4 1.2 0.81
Previous CABG 7.4 7.6 0.91
LVEF <40% 15.8 14 0.13
Stable angina 57 55.1 0.47
IV class CKD 0.4 0.4 0.88
Multivessel CAD 56.4 58.1 0.60
Lesion-related characteristics
CTO site
LAD 30.1 31.5 0.56
RCA 47.9 44.2 0.21
LCX 21.7 23.7 0.36
LM 0.3 0.6 0.31
Ostial CTO 3.7 3.3 0.71
Blunt stump 52 54.6 0.31
Tortuous 15 16.2 0.53
Calciﬁed lesion
Mild 30 28.6
Moderate 18.5 17.8 0.73
Severe 9.3 11.2 0.22
Lesion length $20 mm 34.6 37.6 0.24
Lesion length, mm 20  22.9 20  16.3 0.56
Rentrop class 3 44.1 47.9 0.16
In-stent CTO 10.5 9.2 0.42
J-CTO score 1.63  89 1.59  0.89 0.29
Procedural success 72.4 73 0.53
Values are mean  SD or %.
Abbreviations as in Table 1.
LVEF <40% 15.8 15.8 0.73
Stable angina 52.2 58.8 0.045
IV class CKD 0.3 0.5 0.70
Multivessel CAD 59.9 55.1 0.15
Lesion-related characteristics
CTO site
LAD 20.9 33.6 <0.0001
RCA 47.9 44.2 0.17
LCX 24.7 20.6 0.13
LM 0.6 0.1 0.13
Ostial CTO 4.1 3.5 0.62
Blunt stump 62.1 51.5 0.001
Tortuous 19.4 13.3 0.01
Calciﬁed lesion
Mild 30.4 29.8 0.83
Moderate 21.8 17.3 0.08
Severe 16 6.7 <0.0001
Lesion length $20 mm 47.2 29.9 <0.0001
Lesion length, mm 24.7  20.3 18.2  23.5 <0.0001
Rentrop class 3 46.3 43.3 0.37
In-stent CTO 101.6 10.1 0.46
Values are mean  SD or %.
Abbreviations as in Table 1.Each patient was randomly assigned to the deri-
vation cohort (70%, 1,143 patients), or to the valida-
tion cohort (30%, 514 patients). Except for smoking,
no signiﬁcant differences in terms of clinical and
lesion-related characteristics were reported between
the 2 groups (Table 2).
DERIVATION MODEL UNIVARIABLE ANALYSIS.
The derivation cohort was divided according to
procedural outcome, and clinical and lesion-related
characteristics were analyzed (Table 3). Patients in
whom CTO-PCI failed had a signiﬁcantly higher body
mass index (28.0  4.4 vs. 27.3  3.9; p ¼ 0.024),
higher incidence of dyslipidemia (69.3% vs. 61.8%;
p ¼ 0.018), more frequent history of MI (27.8% vs.
18.0%; p < 0.0001), PCI (44.3% vs. 33.4%; p ¼ 0.001),
and coronary artery bypass surgery (12.3% vs. 5.6%;
TABLE 4 Multivariable Analysis
Overall Population
Univariable Analysis
Stepwise Logistic Regression
p < 0.0001
Failure
(n ¼ 316)
Success
(n ¼ 827) p Value Odds Ratio 95% CI p Value
Dyslipidemia 69.3 61.8 0.018
BMI, kg/m2 28  4.4 27.3  3.9 0.024
Previous MI 27.8 18 <0.0001 1.603 1.172–2.192 0.003
Previous PCI 44.3 33.4 0.001
Previous CABG 12.3 5.6 <0.0001 2.491 1.566–3.963 <0.0001
Stable angina 52.2 58.8 0.045
n-LAD 79.1 66.4 <0.0001 1.566 1.140–2.152 0.006
Blunt stump 51.5 62.1 0.001 1.390 1.051–1.813 0.028
Severe calciﬁcation 16 6.7 <0.0001 2.725 1.782–4.167 <0.0001
Lesion length $20 mm 47.2 29.9 <0.0001 2.044 1.547–2.70 <0.0001
Tortuous 19.4 13.3 0.01
Values are % or mean  SD.
CI ¼ conﬁdence interval; n-LAD ¼ non–left anterior descending coronary artery; other abbreviations as in
Table 1.
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1544p < 0.0001) Stable angina was a less frequent indi-
cation of CTO-PCI in patients in whom PCI was un-
successful (52.2% vs. 58.8%; p ¼ 0.045).
Concerning lesion-related variables, nonrevas-
cularized lesions were less frequently located in the
LAD (20.9% vs. 33.6%; p < 0.0001), more often had a
blunt stump (62.1% vs. 51.5%; p ¼ 0.001), and were
tortuous (19.4% vs. 13.3%; p ¼ 0.01), severely calciﬁed
(16% vs. 6.7%; p < 0.0001), and longer ($20 mm:
47.2% vs. 29.9%; p < 0.0001).
MULTIVARIABLE ANALYSIS. Using a backward step-
wise approach, severe lesion calciﬁcation (OR: 2.72;
95% conﬁdence interval [CI]: 1.78 to 4.16; p < 0.0001),
previous CABG (OR: 2.49; 95% CI: 1.56 to 3.96; p <
0.0001), lesion length $20 mm (OR: 2.04; 95% CI: 1.54
to 2.70; p < 0.0001), previous MI (OR: 1.60, 95% CI:
1.17 to 2.19; p ¼ 0.003) non-LAD location of the lesion
(OR: 1.56, 95% CI: 1.14 to 2.15; p ¼ 0.006), and blunt
morphology of the lesion (OR: 1.39; 95% CI: 1.05 to
1.81; p ¼ 0.028) were all independent predictors of
unsuccessful CTO-PCI (Table 4).TABLE 5 Independent Predictive Variables Scored
According to OR
OR Score
Severe calciﬁed lesion 2.72 þ2
Previous CABG 2.49 þ1.5
Lesion length $20 mm 2.04 þ1.5
Previous MI 1.60 þ1
Blunt stump 1.39 þ1
Non-LAD CTO location 1.56 þ1
OR ¼ odds ratio; other abbreviations as in Table 1.PREDICTIVE SCORE. Independent predictors of un-
successful CTO-PCI were scored according to the
corresponding OR size (Table 5). Four subgroups were
identiﬁed on the basis of the success rate: score
values of 0 to 1 (class 0), >1 and <3 (class 1), $3 and <5
(class 2), and $5 (class 3) corresponding to high, in-
termediate, low, and very low probability, respec-
tively, of CTO-PCI success in the derivation cohort
(p < 0.0001) (Figure 1). According to our score
ranking, the probability of CTO-PCI failure increased
signiﬁcantly from class 0 to class 1 (15.1% to 25.1%;
p ¼ 0.0004), from class 1 to class 2 (25.1% to 41.1%;
p < 0.0001), and from class 2 to class 3 (41.1% to
68.1%; p ¼ 0.0005), respectively.
VALIDATION MODEL ANALYSIS. The predictive
score was then applied to the validation cohort. The
CL-score was also shown to be a strong predictor of
ﬁnal procedural success in the validation cohort
(88.3%, 73.1%, 59.4%, and 46.2% in classes 0 to 3,
respectively; chi-square for trend: p < 0.0001). In a
logistic regression, the ORs of class 1 to 3 with respect
to class 0 were: 2.78 (95% CI: 1.53 to 5.0), 5.15 (95% CI:
2.8 to 9.3), and 8.78 (95% CI: 3.5 to 21.7), respectively
(all p values were <0.0001).
A receiver-operating characteristic curve analysis
of the clinical and lesion-related score (CL-score)
versus J-CTO score carried out in the validation
cohort demonstrated the superior performance of the
CL-score: area under the curve 0.68 (95% CI: 0.63 to
0.73) versus area under the curve 0.60 (95% CI: 0.54
to 0.65), respectively (Figure 2).
SAFETY ENDPOINT. The complication rate was low.
No periprocedural deaths were recorded (<24 h).
Post-procedural MI was reported in 34 patients (2%).
Ostial dissection and pericardiocentesis were re-
ported in 17 (1.0%) and 20 (1.3%) patients, respec-
tively (Table 6). Patients who experienced coronary
ostium dissection were all asymptomatic and did not
require any surgical treatment. Two of 20 patients
with pericardiocentesis required surgical pericardial
drainage.
SUBGROUP ANALYSIS. Our population was divided
into 2 subgroups according to the date of the procedure.
Group A (n ¼ 1,066) and group B (n ¼ 591) included
patients who underwent CTO-PCI between January
2004 and December 2010, and between January 2011
and December 2013, respectively (Figure 3).
The impact of the subgroup variable on ﬁnal pro-
cedural success was found to be statistically signiﬁ-
cant (group A, 70.8%; group B, 75.6%; p ¼ 0.036).
Mean J-CTO score of group A was not statistically
different compared with group B (1.59  0.88 vs.
1.62  0.89; p ¼ 0.27).
FIGURE 1 Procedural Success Rate According to CL-Score Value in the Derivation and Validation Groups
Relationships between the 4 classes based on the clinical and lesion-related score (CL-score) value and probability of ﬁnal procedural success in
the derivation and validation groups. The CL-score was a strong predictor of ﬁnal procedural success in both the validation and derivation
cohorts.
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1545As expected, the availability of new dedicated
devices changed the operators’ approach to CTO-PCI
during the enrolling period (Table 7). In group B, a
larger proportion of transradial procedures (73% vs.
62%; p < 0.001), retrograde approach (15.4% vs.
6.0%; p < 0.0001), and concomitant collateral injec-
tion (50.2% vs. 28.4%; p < 0.0001) was performed.
Coaxial (32.4% vs. 3.9%; p < 0.0001) and monorail
balloon (7.9% vs. 1.8%; p < 0.0001) support and
parallel wire techniques (19.6% vs. 14.4%; p ¼ 0.001),
frequently implemented in group A, were substituted
by use of the microcatheter in the second part of the
study (32.1% vs. 85.6%; p < 0.0001). The Tornus
microcatheter (Asahi Intecc, Nagoya, Japan) was
more frequently used in the ﬁrst part of the study
(2.8% vs. 0.8%; p ¼ 0.008). No differences in the use
of rotational atherectomy, anchor wire, or anchor
balloon technique were reported. In group B, a sig-
niﬁcant reduction in the myocardial infarction rate
was observed (0.8% vs. 2.7%, p ¼ 0.01). On the other
hand, a signiﬁcant increase in the rate of coronary
ostium dissection was reported in group B compared
with group A (2.5% vs. 0.2%; p ¼ 0.0001). Nodifference in pericardiocentesis was observed be-
tween the groups.
DISCUSSION
The score system presented here (CL-score) was
developed on the basis of a prospective single-center
study of 1,657 patients who underwent a ﬁrst CTO-PCI
attempt. To the best of our knowledge, this is the ﬁrst
predictive model of ﬁnal procedural CTO-PCI success
including both clinical and angiographic variables.
Notwithstanding the signiﬁcant increase in success
rates up to more than 85% to 90% reported by the
majority of recent studies, especially in patients
treated using the retrograde or hybrid approach
(16,17), CTO is still the setting in which PCI is associ-
ated with the highest probability of failure. Previ-
ously reported studies have already underlined the
impact of several lesion-related characteristics on the
procedural outcome (18–23). More recently, calciﬁca-
tion, bending, blunt stump, occlusion length $20
mm, and prior failed attempts were included in the J-
CTO validated score as predictors of probability of
FIGURE 2 ROC Curve for Probability of Successful CTO-PCI According to CL-Score and
J-CTO Score
Receiver-operating characteristic (ROC) analysis of the CL-score versus J-CTO score carried
out in the validation cohort demonstrated the superior performance of the CL-score. The
area under the curve was 0.68 for the CL-score and 0.60 for the J-CTO score. CL-score ¼
clinical and lesion-related score; CTO-PCI ¼ chronic total occlusion for percutaneous
coronary intervention; J-CTO score ¼ Japanese chronic total occlusion score.
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1546guidewire crossing and predictors of longer proce-
dural time (8,9). In addition, clinical variables have
been shown to have a negative impact on ﬁnal pro-
cedural success as reported in the most recent CTO-
PCI series even when the hybrid approach was
implemented (11,24,25).
In the study reported here, 2 clinical variables
(history of CABG and history of MI), and 4 lesion-
related variables (blunt stump, lesion calciﬁcation,
non-LAD CTO, and lesion length $20 mm) were
identiﬁed as independent predictors of unsuccessful
CTO-PCI. Given that only ﬁrst-attempt CTO-PCIs were
included in the study, the majority of these pro-
cedures were performed via the antegrade approach.
In instances where the antegrade approach failed, aTABLE 6 Events Reported in the Periprocedural Period
(<24 h After CTO-PCI)
Death (0)
MI 34 (2.0)
Ostial dissection 17 (2.8)
Pericardiocentesis 20 (1.3)
Values are n (%).
CTO-PCI ¼ chronic total occlusion for percutaneous coronary intervention;
MI ¼ myocardial infarction.new procedure was generally attempted via the
retrograde approach. The fact that second attempts
did not meet the inclusion criteria may account for
the low rate of retrograde approach in our study. This,
along with the low rate of contralateral injection and
the relatively long enrollment period, may explain
the relatively low success rate observed in our
population.
A subgroup analysis was carried out to compare
procedures performed in the ﬁrst period (group A)
and in the second period (group B) to minimize the
impact of newly available devices on ﬁnal procedural
success during the enrolling period. The higher suc-
cess rate observed in the second part of the study
suggested a favorable impact of new dedicated de-
vices and increasing experience on the ﬁnal proce-
dural success rate. In addition, the increased
incidence of coronary ostium dissection in group B
was not clinically relevant (no need for surgical
treatment and spontaneous resolution), whereas a
signiﬁcant reduction in post-procedural MI was
observed in the second part of the enrolling period.
The effect of operator expertise on procedural
success was also taken into account. Consensus re-
ports on CTO management specify that patients
scheduled for CTO-PCI should be referred to a skilled
operator. Although a minimum of 75 CTO-PCIs per
operator has been considered a reasonable threshold
to identify a skilled operator (26), no deﬁnite cutoff
value has yet been validated. Although the operators
involved in the study had varying degrees of exper-
tise, all of them were, nevertheless, skilled operators.
Extrapolation analysis of data pertaining to 2 highly
experienced CTO-PCI operators (>300 CTOs each in
this study) who performed CTO-PCIs from 2010 to
2013 (213 procedures, contralateral injection 60%,
retrograde approach 21%) showed an 87.8% success
rate.
An increasing number of operators and centers are
currently building up CTO PCI expertise owing to the
availability of new dedicated devices, techniques,
and training courses organized by expert operators
and to mounting evidence of the beneﬁts of CTO
revascularization compared with medical therapy
(25,27).
Given that the present predictive CL-score was
mainly established on the basis of CTO-PCIs at-
tempted via the antegrade approach, it seems to be
applicable in contemporary settings, especially in
centers where the retrograde/hybrid approach has not
yet been adopted. Pre-procedural assessment of the
probability of success may support the decision to
attempt PCI in a CTO lesion or to refer the patient to a
high-volume CTO-PCI center where the hybrid/
FIGURE 3 Annual Distribution of First-Intention CTO-PCI Procedures
Annual distribution of ﬁrst attempt CTO-PCI performed during the 10-year enrolling period at our center. CTO-PCI ¼ chronic total occlusion for
percutaneous coronary intervention.
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1547retrograde approach is performed. This particularly
applies to patients with a high CL-score, especially
those with chronic renal insufﬁciency, mild angina
(low Canadian Cardiovascular Society classes), or a
modest amount of ischemic burden.
STUDY LIMITATIONS. A few limitations of this anal-
ysis should be taken into account. 1) Given that this
score system was developed from data collected in a
study carried out in a single center on ﬁrst-attempt
CTO-PCI procedures mainly performed via theTABLE 7 Procedural Characteristics of Groups A and B
Group A
(n ¼ 1,066)
Group B
(n ¼ 591) p Value
Femoral access 405 (38.0) 160 (27.0) <0.0001
Retrograde approach 64 (6.0) 91 (15.4) <0.0001
Contralateral injection 303 (28.4) 297 (50.2) <0.0001
Procedural time, min 87.3  46.9 87.5.4  52.6 0.9
Contrast amount, ml 269  164.6 243  137.9 0.002
Monorail balloon support 84 (7.9) 11 (1.8) <0.0001
Coaxial balloon support 346 (32.4) 23 (3.9) <0.0001
Microcatheter support 343 (32.1) 506 (85.6) <0.0001
Parallel wire 150 (19.6) 129 (14.4) 0.0062
Anchor balloon 96 (9.0) 56 (9.5) 0.46
Anchor wire 71 (6.6) 29 (4.9) 0.14
Rotational atherectomy 17 (1.6) 8 (1.3) 0.7
Tornus 30 (2.8) 5 (0.8) 0.008
Final success 755 (70.8) 447 (75.6) 0.036
MI 29 (2.7) 5 (0.8) 0.01
Ostial dissection 2 (0.2) 15 (2.5) 0.0001
Pericardiocentesis 12 (1.2) 8 (1.4) 0.82
Values are n (%) or mean  SD.
MI ¼ myocardial infarction.antegrade approach with a high proportion of expe-
rienced operators, our predictive model cannot be
automatically extrapolated to settings with a
different level of operator experience, previously
attempted procedures, or a different procedural al-
gorithm. 2) Another limitation of our study is the
absence of anatomic evaluation by an external core
laboratory. 3) Other clinical variables, such as the
degree of renal impairment, could have a predictive
impact. 4) As the techniques and CTO-speciﬁc medi-
cal technologies are evolving, the score will require
updating in the future.
CONCLUSIONS
In this single-center study, clinical and angiographic
parameters predicting CTO-PCI procedural success
were identiﬁed and included in a scoring model
system using a backward stepwise approach. This
model allows the identiﬁcation of 4 subgroup score
values corresponding to high, intermediate, low,
and very low probability of CTO-PCI success. The
increasing score values correlate with low probabil-
ity of CTO-PCI success ranging from <50% to more
than 80%. The CL-score outperformed the J-CTO
score in predicting procedural success. The applica-
bility of the score needs to be validated in other
centers.
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PERSPECTIVES
WHAT IS KNOWN? Multiple nonrandomized studies
reported the long-term clinical beneﬁts of successful
CTO-PCI compared with CTO-PCI failure. However, these
results are limited in their application because it is difﬁ-
cult to predict the success of a CTO-PCI.
WHAT IS NEW? We report here the ﬁrst predictive
score of ﬁnal procedural CTO-PCI success. This model
seems to be applicable in centers where the retrograde/
hybrid approach has not yet been implemented.
WHAT IS NEXT? Validation of this predictive model of
CTO-PCI success in a population of patients treated using
a hybrid approach is needed.
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